CANCER BIOSTATISTICS SHARED RESOURCE ABSTRACT The Cancer Biostatistics (CB) Shared Resource provides state-of-the-art biostatistics and research design support to laboratory, translational, clinical, and population sciences investigators at Huntsman Cancer Institute (HCI). It is a section of the University of Utah (U of U) Study Design and Biostatistics Center (SDBC), the biostatistics core of the U of U Health Sciences Center and its National Institutes of Health Clinical and Translational Science Award-supported Center for Clinical and Translational Science (CCTS). The CB Shared Resource is led by Kenneth Boucher, PhD, an accomplished biostatistician and a Cancer Center member since 1996, and includes five personnel with specialized cancer research expertise. Dr. Boucher works in close coordination with Tom Greene, PhD, SDBC Director, a senior biostatistician with more than 25 years of experience serving as the lead statistician for NIH- and industry-sponsored multi-center clinical trials and other large-scale multidisciplinary research efforts. The CB Shared Resource arranges statistical teams to support all stages of the research process to benefit Cancer Center members, providing HCI researchers with integrated statistical and epidemiologic expertise in study design, health measurement, and data analysis. This expertise includes clinical trial and observational study design, longitudinal data analysis, linear and nonlinear mixed effects models, survival analysis, multivariate methods, meta-analysis, Bayesian models, computational statistics, diagnostic testing, comparative effectiveness research, modern causal inference, survey design and questionnaire development, item response theory and computer adaptive testing, and statistical genetics and genomics. In addition to providing statistical analyses, the CB Shared Resource provides guidance in formulation of research objectives, development of informative and efficient study designs, implementation of randomized procedures, design and implementation of surveys, selection of appropriate instruments and development of new instruments for measurement of health outcomes, development of appropriate procedures for collection and secure storage of data, collaborative formulation of pre-specified analysis plans prior to data analysis, and interpretation and presentation of data in publications and oral presentations. The CB Shared Resource is located in the HCI building, providing direct on-site access to resource users throughout all stages of the research process. The importance of the CB Shared Resource is demonstrated by its wide array of users and its contributions to numerous publications, many in high-profile journals. In 2013, use of the CB Shared Resource by Cancer Center investigators with peer-reviewed funding exceeded 66%, while the CCSG budget request is only 6% ($46,388) of the total proposed budget.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA042014-29
Application #
9478883
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-05-01
Budget End
2019-04-30
Support Year
29
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Li, Lian; Yang, Jiyuan; Wang, Jiawei et al. (2018) Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 12:3658-3670
Wu, Yelena P; Nagelhout, Elizabeth; Aspinwall, Lisa G et al. (2018) A novel educational intervention targeting melanoma risk and prevention knowledge among children with a familial risk for melanoma. Patient Educ Couns 101:452-459
Tiburcio, Patricia D B; Xiao, Bing; Chai, Yi et al. (2018) IDH1R132H is intrinsically tumor-suppressive but functionally attenuated by the glutamate-rich cerebral environment. Oncotarget 9:35100-35113
Ferris, Elliott; Abegglen, Lisa M; Schiffman, Joshua D et al. (2018) Accelerated Evolution in Distinctive Species Reveals Candidate Elements for Clinically Relevant Traits, Including Mutation and Cancer Resistance. Cell Rep 22:2742-2755
Liang, Wenjie; Yang, Pengfei; Huang, Rui et al. (2018) A Combined Nomogram Model to Preoperatively Predict Histologic Grade in Pancreatic Neuroendocrine Tumors. Clin Cancer Res :
Ou, Judy Y; Fowler, Brynn; Ding, Qian et al. (2018) A statewide investigation of geographic lung cancer incidence patterns and radon exposure in a low-smoking population. BMC Cancer 18:115
Peres, Lauren C; Cushing-Haugen, Kara L; Anglesio, Michael et al. (2018) Histotype classification of ovarian carcinoma: A comparison of approaches. Gynecol Oncol 151:53-60
Vázquez-Arreguín, Karina; Maddox, Jessica; Kang, Jinsuk et al. (2018) BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism. Mol Cancer Res 16:439-452
Himbert, Caroline; Ose, Jennifer; Nattenmüller, Johanna et al. (2018) Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer: the ColoCare Study. Cancer Epidemiol Biomarkers Prev :
Zeng, Tao; Fleming, Aaron M; Ding, Yun et al. (2018) Nanopore Analysis of the 5-Guanidinohydantoin to Iminoallantoin Isomerization in Duplex DNA. J Org Chem 83:3973-3978

Showing the most recent 10 out of 1193 publications